Product development

Lead Pharma is a biopharmaceutical company focusing on the discovery and development of innovative medicines for the treatment of autoimmune diseases and cancer. Lead Pharma’s drug discovery engine combines medicinal, structural, and computational chemistry with molecular pharmacology, cell and tissue-based pharmacology. Thereby, the company aims to identify first and / or best-in-class small molecule drugs.

Based in Nijmegen and Oss, the Netherlands, Lead Pharma is privately owned and is financed by Biox Biosciences, Participatiemaatschappij Oost Nederland N.V. (PPM Oost), Life Sciences & Health Fund B.V., and Technostartersfonds Zuid Nederland B.V.

Area of work

Drug discovery, Drug development, Oncology, Ageing related diseases, Precision medicine

``To take steps forward you need good facilities. They are fully present at the Pivot Park, with its high-quality laboratories. In addition, you are based on a park in an environment with other pharma companies, which can open the way to new partnerships.``

News from Lead Pharma

Synergy between biopharma and academia

06 Aug 21

Lead Pharma enters into a Research Collaboration with Roche

17 Nov 20

Lead Pharma Announces Start of Phase I Clinical Trials with SAR441169 Candidate Treatment for Psoriasis

25 Mar 19